Stabilized Synthetic Immunogen Delivery System

Details for Australian Patent Application No. 2003213091 (hide)

Owner United Biomedical, Inc.

Inventors Sokoll, Kenneth K

Agent Spruson & Ferguson

Pub. Number AU-B-2003213091

PCT Number PCT/US03/04711

PCT Pub. Number WO2003/068169

Priority 10/355,161 31.01.03 US; 10/076,674 14.02.02 US

Filing date 14 February 2003

Wipo publication date 4 September 2003

Acceptance publication date 5 June 2008

International Classifications

A61K 39/40 (2006.01) Medicinal preparations containing antigens or antibodies - bacterial

A61K 6/00 (2006.01) Preparations for dentistry

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/107 (2006.01) Medicinal preparations characterised by special physical form - Emulsions

A61K 9/68 (2006.01) Medicinal preparations characterised by special physical form - chewing gum type

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 39/295 (2006.01) Medicinal preparations containing antigens or antibodies - Polyvalent viral antigens

A61K 39/38 (2006.01) Medicinal preparations containing antigens or antibodies - Antigens from snakes

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

A61K 47/26 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carbohydrates

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61M 36/14 (2006.01) Applying radioactive material to the body

A61P 15/16 (2006.01) Drugs for genital or sexual disorders

A61P 15/18 (2006.01) Drugs for genital or sexual disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 10/355,161 31.01.03 US; 10/076,674 14.02.02 US

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2003213091

19 August 2004 Amendment Made

  The nature of the amendment is: Add the second priority details of 10/355,161 31 Jan 2003 US.

5 June 2008 Application Accepted

  Published as AU-B-2003213091

28 August 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 04 Aug 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

8 January 2009 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 04 Aug 2008

8 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003213092-SYNTHESES OF QUINAZOLINONES

2003213090-RNA interference mediated treatment of alzheimer's disease using short interfering nucleic acid ( siNA)